
|Videos|February 25, 2015
FDA's Compounding Advisory Committee's Effects for Compounding Pharmacists
Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA's Compounding Advisory Committee will affect the daily practice of compounding pharmacists.
Advertisement
Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA’s Compounding Advisory Committee will affect the daily practice of compounding pharmacists.
This interview was recorded at the Pharmacy Development Services 2015 conference in Orlando, Florida.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
Darovasertib Plus Crizotinib Shows Striking Efficacy in HLA-A2–Negative Metastatic Uveal Melanoma, OptimUM-02 Results Show
3
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
4
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
5








































































































































